1 Min Read
Oct 16 (Reuters) - DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB (PUBL):
* NO SERIOUS ADVERSE EFFECTS IN GLP-TOX PRELIMINARY STUDY FOR TEMODEX Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.